FUJIFILM Corporation News and Resources

FUJIFILM Corporation has made a significant move in the pharmaceutical industry by investing an additional $1.2 billion in its Large-Scale Cell Culture Contract Development and Manufacturing Organisation (CDMO) Business. This investment is aimed at expanding the planned FUJIFILM Diosynth Biotechnologies end-to-end